Sonnet Biotherapeutics Holdings Inc
SONN2.635USD
-0.175-6.23%
交易中 （美東）報價延遲15分鐘
8.23M總市值
虧損本益比TTM
關於 Sonnet Biotherapeutics Holdings Inc 公司
Sonnet BioTherapeutics Holdings, Inc. 是一家臨牀階段、專注於腫瘤學的生物技術公司，擁有專有的單功能或雙功能生物藥物平臺。全人白蛋白結合 (FHAB) 是一種利用全人單鏈抗體片段與人血清白蛋白結合並搭便車運輸到目標組織的技術。其 FHAB 旨在專門針對腫瘤和淋巴組織。該公司的領先項目 SON-1010 或 IL-12-FHAB 正在開發中，用於治療實體瘤和卵巢癌。SON-1010 正在進行 1/2a 期研究，與阿替利珠單抗 (Tecentriq) 聯合用於治療鉑耐藥性卵巢癌 (PROC)。該公司還在評估其第二個項目 SON-1210，這是一種用於實體瘤的 IL12-FHAB-IL15。其 SON-080 項目是一種低劑量 rhIL-6，用於治療化療引起的周圍神經病變 (CIPN) 和糖尿病周圍神經病變 (DPN)。
公司簡介
公司代碼SONN
公司名稱Sonnet Biotherapeutics Holdings Inc
上市日期Jul 27, 2005
CEOMr. Raghu Rao
員工數量13
證券類型Ordinary Share
年結日Jul 27
公司地址100 Overlook Center
城市PRINCETON
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編08540
電話16093752227
網址https://www.sonnetbio.com/
公司代碼SONN
上市日期Jul 27, 2005
CEOMr. Raghu Rao
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Raghu Rao
Mr. Raghu Rao
Interim Chief Executive Officer, Director
Interim Chief Executive Officer, Director
22.36K
+848.90%
Dr. John K. Cini, Ph.D.
Dr. John K. Cini, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
14.12K
+567.11%
Mr. Nailesh Bhatt
Mr. Nailesh Bhatt
Independent Director
Independent Director
10.55K
+1828.15%
Ms. Susan Dexter
Ms. Susan Dexter
Chief Technical Officer
Chief Technical Officer
8.37K
+2139.04%
Dr. Richard T. Kenney, M.D.
Dr. Richard T. Kenney, M.D.
Chief Medical Officer
Chief Medical Officer
8.26K
+3053.44%
Ms. Lori Mcneill
Ms. Lori Mcneill
Independent Director
Independent Director
4.39K
+1015.23%
Mr. Albert D. Dyrness
Mr. Albert D. Dyrness
Independent Director
Independent Director
537.00
+227.44%
Mr. Donald J. Griffith, CPA
Mr. Donald J. Griffith, CPA
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Dr. Stephen Mcandrew, Ph.D.
Dr. Stephen Mcandrew, Ph.D.
President and Chief Business Officer
President and Chief Business Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Raghu Rao
Mr. Raghu Rao
Interim Chief Executive Officer, Director
Interim Chief Executive Officer, Director
22.36K
+848.90%
Dr. John K. Cini, Ph.D.
Dr. John K. Cini, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
14.12K
+567.11%
Mr. Nailesh Bhatt
Mr. Nailesh Bhatt
Independent Director
Independent Director
10.55K
+1828.15%
Ms. Susan Dexter
Ms. Susan Dexter
Chief Technical Officer
Chief Technical Officer
8.37K
+2139.04%
Dr. Richard T. Kenney, M.D.
Dr. Richard T. Kenney, M.D.
Chief Medical Officer
Chief Medical Officer
8.26K
+3053.44%
Ms. Lori Mcneill
Ms. Lori Mcneill
Independent Director
Independent Director
4.39K
+1015.23%
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月16日 週五
更新時間: 5月16日 週五
持股股東
股東類型
持股股東
持股股東
佔比
MMCAP Asset Management
2.13%
Geode Capital Management, L.L.C.
0.40%
Markey (John)
0.40%
Rao (Raghu)
0.36%
Mohan (Pankaj)
0.25%
Other
96.47%
持股股東
持股股東
佔比
MMCAP Asset Management
2.13%
Geode Capital Management, L.L.C.
0.40%
Markey (John)
0.40%
Rao (Raghu)
0.36%
Mohan (Pankaj)
0.25%
Other
96.47%
股東類型
持股股東
佔比
Hedge Fund
2.17%
Individual Investor
2.03%
Investment Advisor/Hedge Fund
0.40%
Investment Advisor
0.11%
Other
95.29%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
42
216.94K
3.73%
-6.57K
2025Q1
49
216.94K
6.86%
-38.71K
2024Q4
47
142.46K
4.65%
-26.07K
2024Q3
47
41.15K
2.68%
-136.57K
2024Q2
52
111.48K
15.39%
+15.28K
2024Q1
53
47.27K
6.49%
-61.26K
2023Q4
55
63.31K
18.25%
-49.43K
2023Q3
54
43.80K
20.23%
-50.04K
2023Q2
52
54.80K
26.54%
-1.94K
2023Q1
46
43.66K
38.19%
+40.95K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
MMCAP Asset Management
133.59K
4.22%
+133.59K
--
Mar 31, 2025
Geode Capital Management, L.L.C.
24.80K
0.78%
+24.80K
--
Mar 31, 2025
Markey (John)
24.79K
0.78%
-4.10K
-14.20%
Jan 02, 2024
Rao (Raghu)
2.36K
0.07%
+373.00
+18.81%
Dec 16, 2024
Mohan (Pankaj)
15.37K
0.49%
+7.55K
+96.61%
Dec 16, 2024
Cini (John K)
2.12K
0.07%
+1.89K
+828.07%
Dec 16, 2024
Bhatt (Nailesh)
547.00
0.02%
+373.00
+214.37%
Dec 16, 2024
Griffith (Donald J. CPA)
375.00
0.01%
+317.00
+546.55%
Dec 16, 2024
Dexter (Susan)
374.00
0.01%
+182.00
+94.79%
Dec 11, 2023
Kenney (Richard T)
262.00
0.01%
+159.00
+154.37%
Dec 11, 2023
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Sep 12, 2024
Merger
8<1
Sep 12, 2024
Merger
8<1
Sep 12, 2024
Merger
8<1
Sep 12, 2024
Merger
8<1
Aug 31, 2023
Merger
22<1
Aug 31, 2023
Merger
22<1
公告日期
類型
比率
Sep 12, 2024
Merger
8<1
Sep 12, 2024
Merger
8<1
Sep 12, 2024
Merger
8<1
Sep 12, 2024
Merger
8<1
Aug 31, 2023
Merger
22<1
Aug 31, 2023
Merger
22<1
Aug 31, 2023
Merger
22<1
Aug 31, 2023
Merger
22<1
Sep 16, 2022
Merger
14<1
Sep 16, 2022
Merger
14<1
查看更多
